A detailed history of Prelude Capital Management, LLC transactions in Viatris Inc stock. As of the latest transaction made, Prelude Capital Management, LLC holds 358,890 shares of VTRS stock, worth $4.49 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares
358,890
Previous 358,890 -0.0%
Holding current value
$4.49 Million
Previous $4.17 Million -0.0%
% of portfolio
0.27%
Previous 0.16%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$10.32 - $12.13 $154,820 - $181,974
-15,002 Reduced 4.01%
358,890 $4.17 Million
Q2 2024

Aug 14, 2024

BUY
$10.05 - $12.02 $973,030 - $1.16 Million
96,819 Added 34.94%
373,892 $3.97 Million
Q1 2024

May 15, 2024

BUY
$11.27 - $13.53 $3.12 Million - $3.75 Million
277,073 New
277,073 $3.31 Million
Q3 2022

Nov 14, 2022

BUY
$8.48 - $11.13 $162,188 - $212,872
19,126 New
19,126 $163,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.2B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Prelude Capital Management, LLC Portfolio

Follow Prelude Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prelude Capital Management, LLC with notifications on news.